Alkermes (ALKS) Common Equity (2010 - 2026)
Alkermes (ALKS) recorded Common Equity of $1.86 billion in Q3 2026, up 7.6% from $1.73 billion a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Alkermes reported Common Equity of $1.82 billion, up 24.2% from FY2024.
- Annual Common Equity has increased for three straight years, with a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $1.46 billion in FY2024 (+21.8%), $1.2 billion in FY2023 (+15.2%), $1.04 billion in FY2022 (-6.2%) and $1.11 billion in FY2021 (+4.3%).
- The Q3 2026 figure is the highest quarterly Common Equity in data going back to Q1 2013.
- On a year-over-year basis, Common Equity has increased for eight consecutive quarters, with growth averaging 20.2% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 34.2% in Q3 2025, against a decline of 6.5% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.81 billion (Q2 2026), $1.75 billion (Q1 2026) and $1.82 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 1.86 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.86 Bn |
| Jun 30, 2026 | 1.81 Bn |
| Mar 31, 2026 | 1.75 Bn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 1.73 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.51 Bn |
| Dec 31, 2024 | 1.46 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.28 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.11 Bn |
API Access
Alkermes Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();